成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 135062-02-1 Chemical Structure| 135062-02-1

Structure of Repaglinide
CAS No.: 135062-02-1

Chemical Structure| 135062-02-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 135062-02-1

,{[proInfo.pro_purity]}

Repaglinide is a carbamoylmethyl benzoic acid (CMBA) derivative, which recently has become available for the treatment of type II diabetes.

Synonyms: AG-EE 623ZW

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Repaglinide

CAS No. :135062-02-1
Formula : C27H36N2O4
M.W : 452.59
SMILES Code : CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N2CCCCC2)=C1)C(O)=O
Synonyms :
AG-EE 623ZW
MDL No. :MFCD00906179
InChI Key :FAEKWTJYAYMJKF-QHCPKHFHSA-N
Pubchem ID :65981

Safety of Repaglinide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H361-H362
Precautionary Statements:P501-P263-P260-P270-P202-P201-P264-P280-P308+P313-P301+P312+P330-P405

Isoform Comparison

Biological Activity

Target
  • Potassium Channel

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03492580 - Completed - United States, New Jersey ... More >> Janssen Investigative Site Titusville, New Jersey, United States, 08560 Less <<
NCT01974544 Type 2 Diabetes Not Applicable Unknown December 2016 Chile ... More >> Pontificia Universidad Católica de Chile Recruiting Santiago, Región Metropolitana, Chile, 8330033 Contact: Castillo Alejandra, Nurse ?? 56223543527 ?? macastia@uc.cl ?? Contact: Vega Andrea, Nurse ?? 56223543879 ?? abvega@uc.cl ?? Principal Investigator: Boza Camilo, MD surgeon ?? ?? ?? Sub-Investigator: Valderas Juan Patricio, MD ?? ?? ?? Sub-Investigator: Arrese Marco, MD Internist ?? ?? ?? Sub-Investigator: Mu?oz Rodrigo, MD Less <<
NCT02456428 - Completed - Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT00000620 Atherosclerosis ... More >> Cardiovascular Diseases Hypercholesterolemia Hypertension Diabetes Mellitus, Type 2 Diabetes Mellitus Coronary Disease Less << Phase 3 Completed - United States, Minnesota ... More >> Minneapolis Medical Research Foundation Minneapolis, Minnesota, United States, 55404 United States, New York Columbia University New York, New York, United States, 10027 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27106 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Tennessee Veterans Affairs Memphis, Tennessee, United States, 38104 United States, Washington University of Washington Seattle, Washington, United States, 98195 Canada, Ontario McMaster University Hamilton, Ontario, Canada Less <<
NCT01798706 Type 2 Diabetes Phase 3 Completed - -
NCT02476760 - Completed - Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT02475499 - Completed - Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT02616666 Type 2 Diabetes Mellitus Phase 4 Recruiting December 31, 2021 -
NCT01697592 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01798706 - Completed - -
NCT00133718 Type 2 Diabetes Mellitus Phase 4 Completed - Norway ... More >> Asker and Baerum Hospital, Medical Department RUD, Norway, 1309 Less <<
NCT01188525 Healthy Volunteers Phase 1 Completed - France ... More >> Center of clinical investigation Paris, France, 75018 Less <<
NCT03723395 Drug-drug Interaction Phase 1 Recruiting November 2018 United States, Florida ... More >> Covance Clinical Research Unit Recruiting Daytona Beach, Florida, United States, 32117 Contact: Michelle Saint Pierre ?? 386-366-6428 ?? michelle.saintpierre@covance.com ?? Principal Investigator: Hugh Coleman ?? ?? ?? United States, Texas Covance Clinical Research Unit Recruiting Dallas, Texas, United States, 75247 Contact: Iona Tihina ?? 469-513-6716 ?? Ioana.Tihina@covance.com ?? Principal Investigator: Jennifer Zon Less <<
NCT02143765 Type 2 Diabetes Mellitus Phase 4 Completed - China, Jiangsu ... More >> The First People's Hospital of Changzhou Changzhou, Jiangsu, China The Second People's Hospital of Huai'an Huai'an, Jiangsu, China Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, Southeast University Nanjing, Jiangsu, China Xuzhou Central Hospital Xuzhou, Jiangsu, China Yancheng City No.1 People's Hospital Yancheng, Jiangsu, China Zhenjiang First People's Hospital Zhenjiang, Jiangsu, China Less <<
NCT01697592 - Completed - -
NCT03563287 Obesity, Morbid ... More >> Bariatric Surgery Candidate Less << Not Applicable Completed - Finland ... More >> University of Eastern Finland Kuopio, Finland Less <<
NCT01508949 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - Denmark ... More >> Novo Nordisk Investigational Site Frederiksberg C, Denmark, 1958 Less <<
NCT03028103 Diffuse Large B Cell Lymphoma ... More >> Primary Mediastinal Lymphoma Mantle Cell Lymphoma Advanced Solid Tumor Marginal Zone Lymphoma Less << Phase 1 Recruiting September 2019 United States, Arizona ... More >> University of Arizona Cancer Center Recruiting Tucson, Arizona, United States, 85719 United States, Florida Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 United States, New York Columbia University Medical Center Active, not recruiting New York, New York, United States, 10032 Less <<
NCT03359837 Type 2 Diabetes Mellitus Phase 4 Recruiting November 7, 2019 China ... More >> Recruiting Not Listed, China Less <<
NCT00072904 Cystic Fibrosis ... More >> Diabetes Mellitus Less << Phase 3 Completed - United States, California ... More >> Stanford University Palo Alto, California, United States, 94304 United States, Massachusetts Baystate Medical Center Springfield, Massachusetts, United States, 01199 United States, Minnesota University of Minnesota Medical Center Minneapolis, Minnesota, United States, 55455 United States, Pennsylvania Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213-2583 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-2650 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132-4701 Canada, Ontario St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Less <<
NCT00662714 Cystic Fibrosis ... More >> Diabetes Mellitus Less << Phase 3 Completed - Austria ... More >> Universit?tsklinik für Kinder- und Jugendheilkunde Graz, Austria, 8036 Universit?tsklinik für Kinder- und Jugendheilkunde Wien, Austria, 1090 France CRCM adultes Lille, France, 59037 CRCM adultes, Centre Hospitalier Lyon Sud Lyon, France, 69495 APHP, CRCM pediatrique, Hopital Necker Paris, France, 75015 APHP, CRCM pediatrique, Hopital Robert Debre Paris, France, 75019 APHP, CRCM pediatrique, Hopital Cochin Paris, France, 75679 CRCM adultes, Hopital Civil Strasbourg, France, 67000 Germany Helios Klinikum Emil von Behring Berlin, Germany, 12200 Heliosklinikum Berlin-Buch Berlin, Germany, 13125 Prof.-Hess-Kinderklinik/ Zentralkrankenhaus Bremen, Germany, 28205 Zentralkrankenhaus "Links der Weser" Bremen, Germany, 28277 Universit?tskinderklinik Düsseldorf Düsseldorf, Germany, 40225 Klinik für Kinder und Jugendliche Erlangen Erlangen, Germany, 91054 Universit?tsklinikum Essen Essen, Germany, 45147 Ruhrlandklinik Essen Essen, Germany, 45239 Zentrum für Kinderheilkunde Frankfurt Frankfurt, Germany, 60590 Med. Klinik II, Allergologie und Pneumologie Frankfurt, Germany, 60596 Klinik Schillerh?he Gerlingen, Germany, 70839 Klinik und Poliklinik für Kinder- und Jugendmedizin Greifswald, Germany, 17475 Altona - Klinik Hamburg, Germany, 22763 Medizinische Hochschule Hannover, Abt. Kinderheilkunde Hannover, Germany, 30625 Medizinische Hochschule Hannover, CF-Ambulanz f. Erwachsene Hannover, Germany, 30625 Klikum der Universit?t Heidelberg, Kinderklinik Heidelberg, Germany, 69120 Universit?tsklinik für Kinder- und Jugendmedizin Homburg, Germany, 66421 Kinderkrankenhaus Park Sch?nfeld Kassel, Germany, 34121 St?dtisches Krankenhaus Kiel Kiel, Germany, 24116 Klinik und Poliklinik für allgemeine Kinderheilkunde K?ln, Germany, 50937 Universit?tsklinik Mainz Mainz, Germany, 55101 Clemenshospital Münster, Germany, 48153 Elisabeth Kinderkrankenhaus Oldenburg, Germany, 26133 Kinderhospital Osnabrück Osnabrück, Germany, 49082 Kinderklinik Dritter Orden, Sozialp?diatrisches Zentrum Passau, Germany, 94032 Universit?tsklinik für Kinder- und Jugendmedizin Tübingen, Germany, 72076 Julius-Maximilians Universit?t, Kinderpoliklinik Würzburg, Germany, 97080 Italy Centro Fibrosi Cistica Verona, Italy, 37100 Less <<
NCT01919489 Type 2 Diabetes Phase 4 Recruiting June 2019 United States, Florida ... More >> University of Miami Recruiting Miami, Florida, United States Contact: Gianluca Iacobellis, MD ?? ?? GIacobellis@med.miami.edu ?? Principal Investigator: Gianluca Iacobellis, MD ?? ?? ?? United States, Georgia Grady Memorial Hospital Recruiting Atlanta, Georgia, United States, 30303 Contact: Guillermo E Umpierrez, MD ?? 404-778-1665 ?? geumpie@emory.edu ?? Contact: Francisco J Pasquel, MD ?? 404 778 1697 ?? fpasque@emory.edu ?? Principal Investigator: Guillermo Umpierrez, MD ?? ?? ?? Sub-Investigator: Francisco J Pasquel, MD ?? ?? ?? Sub-Investigator: Priya Vellanki, MD ?? ?? ?? Emory University Hospital Recruiting Atlanta, Georgia, United States, 30324 Contact: Francisco Pasquel, MD ?? ?? fpasque@emory.edu ?? Sub-Investigator: Francisco Pasquel, MD ?? ?? ?? Emory Universtiy Hospital at MIdtown Recruiting Atlanta, Georgia, United States Contact: Francisco Pasquel, MD ?? ?? ?? Sub-Investigator: Rodolfo J Galindo, MD ?? ?? ?? United States, New York State University of NY at Buffalo Recruiting New York, New York, United States Contact: Ajay Chaudhuri, MD ?? ?? AChaudhuri@KaleidaHealth.Org ?? Principal Investigator: Ajay Chaudhuri, MD Less <<
NCT01140438 Diabetes Not Applicable Active, not recruiting December 2018 Norway ... More >> Valdemar Grill Trondheim, Norway, 7006 Less <<
NCT00000620 - Completed - -
NCT00118963 Diabetes Mellitus, Type 2 Phase 4 Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Less <<
NCT01720303 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Beijing ... More >> Novo Nordisk Investigational Site Beijing, Beijing, China, 100101 China, Shanghai Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200040 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200433 Less <<
NCT02694263 Diabetes Mellitus, Type 2 Phase 4 Recruiting September 2018 United Kingdom ... More >> University Hospitals of Leicester NHS Trust Recruiting Leicester, Leicestershire, United Kingdom, LE5 4PW Contact: Emer Brady, PhD ?? 0116248 ext 8959 ?? emer.brady@uhl-tr.nhs.uk ?? Contact: Natasha Wileman, MSc ?? 0116258 ext 8929 ?? natasha.wileman@uhl-tr.nhs.uk ?? University Hospitals Birmingham NHS Foundation Trust Recruiting Birmingham, West Midlands, United Kingdom, B15 2TH Contact: Wasim Hanif ?? 0121371 ext 4404 ?? wasim.hanif@uhb.nhs.uk ?? Contact: Deborah Smith ?? 0121371 ext 4707 ?? deborah.smith@uhb.nhs.uk Less <<
NCT00568074 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Shanghai ... More >> Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200025 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200433 China, Sichuan Novo Nordisk Investigational Site Chengdu, Sichuan, China, 610041 China Novo Nordisk Investigational Site Beijing, China, 100029 Less <<
NCT00799448 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Terminated(Low recruitment sta... More >>tus) Less << - Greece ... More >> Novo Nordisk Investigational Site Athens, Greece, 15127 Less <<
NCT00399711 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01709305 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT00568984 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Beijing ... More >> Novo Nordisk Investigational Site Beijing, Beijing, China, 100034 Novo Nordisk Investigational Site Beijing, Beijing, China, 100044 Novo Nordisk Investigational Site Beijing, Beijing, China, 100730 China, Tianjin Novo Nordisk Investigational Site Tianjin, Tianjin, China, 300052 Malaysia Novo Nordisk Investigational Site Cheras, Malaysia, 56000 Novo Nordisk Investigational Site Ipoh, Malaysia, 30450 Novo Nordisk Investigational Site Kota Bharu, Kelantan, Malaysia, 16150 Philippines Novo Nordisk Investigational Site Cebu City, Philippines, 6000 Novo Nordisk Investigational Site Manila, Philippines, 1003 Novo Nordisk Investigational Site Marikina City, Philippines, 1800 Novo Nordisk Investigational Site Pampanga, Philippines, 2000 Novo Nordisk Investigational Site Quezon City, Philippines, 1100 Novo Nordisk Investigational Site Quezon, Philippines, 4301 Thailand Novo Nordisk Investigational Site Bangkok, Thailand, 10300 Novo Nordisk Investigational Site Bangkok, Thailand, 10330 Less <<
NCT01562561 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Hong Kong ... More >> Novo Nordisk Investigational Site Shatin, New Territories, Hong Kong Malaysia Novo Nordisk Investigational Site Kota Bharu, Kelantan, Malaysia, 16150 Philippines Novo Nordisk Investigational Site Marikina City, Philippines, 1800 Novo Nordisk Investigational Site Pasig City, Philippines, 1605 Novo Nordisk Investigational Site Quezon City, Philippines, 1100 South Africa Novo Nordisk Investigational Site Johannesburg, Gauteng, South Africa, 2193 Novo Nordisk Investigational Site Pretoria, Gauteng, South Africa Novo Nordisk Investigational Site Durban, KwaZulu-Natal, South Africa, 4001 Novo Nordisk Investigational Site Brits, North West, South Africa, 0250 Novo Nordisk Investigational Site Cape Town, Western Cape, South Africa, 7460 Novo Nordisk Investigational Site Alberton, South Africa, 1449 Taiwan Novo Nordisk Investigational Site Tainan city, Taiwan, 710 Less <<
NCT01698931 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Italy ... More >> Novo Nordisk Investigational Site Padova, Italy, 35137 Less <<
NCT01709305 - Completed - -
NCT01720290 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Beijing ... More >> Novo Nordisk Investigational Site Beijing, Beijing, China, 100191 China Novo Nordisk Investigational Site Beijing, China, 100029 Novo Nordisk Investigational Site Shanghai, China Less <<
NCT00118950 Diabetes Mellitus, Type 2 Phase 4 Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Less <<
NCT00491725 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Beijing ... More >> Beijing, Beijing, China, 100034 Less <<
NCT00763412 - Completed - -
NCT01465152 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Spain ... More >> Novo Nordisk Investigational Site Barcelona, Spain, 08020 Novo Nordisk Investigational Site Benamargosa, Spain, 29718 Novo Nordisk Investigational Site Burlada, Spain, 31600 Novo Nordisk Investigational Site Camas, Spain, 41900 Novo Nordisk Investigational Site Fuenlabrada, Spain, 28942 Novo Nordisk Investigational Site Gijón, Spain, 33212 Novo Nordisk Investigational Site Granada, Spain, 18012 Novo Nordisk Investigational Site Lugo, Spain, 27004 Novo Nordisk Investigational Site Madrid, Spain, 28021 Novo Nordisk Investigational Site Madrid, Spain, 28030 Novo Nordisk Investigational Site Madrid, Spain, 28035 Novo Nordisk Investigational Site Portugalete, Spain, 48920 Novo Nordisk Investigational Site San Adria del Besos, Spain, 08930 Novo Nordisk Investigational Site Santander, Spain, 39009 Novo Nordisk Investigational Site Santander, Spain, 39011 Novo Nordisk Investigational Site Tegueste, Spain, 38280 Novo Nordisk Investigational Site Valencia, Spain, 46021 Novo Nordisk Investigational Site Zaragoza, Spain, 50007 Less <<
NCT00231192 Diabetes Not Applicable Withdrawn(Unable to recruit an... More >>y subjects) Less << - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4399 Less <<
NCT01498900 - Completed - Turkey ... More >> Novo Nordisk Investigational Site Istanbul, Turkey, 34335 Less <<
NCT00763412 Cystic Fibrosis Related Diabet... More >>es Pancreatic Insufficiency Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00336310 Diabetes Mellitus, Type 2 PHASE4 UNKNOWN - National Cheng-Kung University... More >> Hospital, Tainan, 704, Taiwan|National Cheng-Kung University Hospital, Tainan, 704, Taiwan Less <<
NCT00451620 Type 2 Diabetes Phase 2 Completed - Canada, British Columbia ... More >> University of British Columbia Vancouver, British Columbia, Canada Less <<
NCT01022762 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Shanghai ... More >> Shanghai, Shanghai, China, 200025 Less <<
NCT01022762 - Completed - -
NCT00709917 - Completed - Belgium ... More >> Brussels, Belgium, 1070 Luxembourg Luxembourg, Luxembourg Less <<
NCT01077570 - Completed - China, Beijing ... More >> Beijing, Beijing, China, 100004 Less <<
NCT01490658 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - United States, Texas ... More >> Novo Nordisk Investigational Site Austin, Texas, United States, 78744 Less <<
NCT01605773 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - United States, Texas ... More >> Novo Nordisk Investigational Site Houston, Texas, United States, 77030 Less <<
NCT01536366 Parkinson Disease Phase 1 Completed - Portugal ... More >> Bial - Portela & Ca, S.A. S. Mamede do Coronado, Portugal, 4745-457 Less <<
NCT01536366 - Completed - -
NCT01498913 - Completed - Korea, Republic of ... More >> Novo Nordisk Investigational Site Seoul, Korea, Republic of, 137-920 Less <<
NCT01355718 - Completed - Korea, Republic of ... More >> Seoul, Korea, Republic of, 137-920 Less <<
NCT00745433 - Completed - Belgium ... More >> Brussels, Belgium, 1070 Less <<
NCT01489644 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - United States, Florida ... More >> Novo Nordisk Investigational Site Miami, Florida, United States, 33169 United States, Washington Novo Nordisk Investigational Site Tacoma, Washington, United States, 98418 Less <<
NCT02305901 Healthy Phase 1 Completed - Germany ... More >> 1307.20.1 Boehringer Ingelheim Investigational Site Biberach, Germany Less <<
NCT02040246 Diabetes Mellitus, Type 2 Phase 4 Completed - China, Shanghai ... More >> Renji Hospital Shanghai, Shanghai, China, 200127 China Renji Hospital Shanghai, China, 200127 Less <<
NCT00819741 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Fujian ... More >> Novo Nordisk Investigational Site Fuzhou, Fujian, China, 350001 China, Jiangsu Novo Nordisk Investigational Site Nanjing, Jiangsu, China, 210009 Novo Nordisk Investigational Site Nanjing, Jiangsu, China, 210012 Novo Nordisk Investigational Site Nanjing, Jiangsu, China, 210029 Novo Nordisk Investigational Site Suzhou, Jiangsu, China, 215004 Novo Nordisk Investigational Site Wuxi, Jiangsu, China, 214023 China, Jiangxi Novo Nordisk Investigational Site Nanchang, Jiangxi, China, 330006 China, Shanghai Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200001 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200025 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200072 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200092 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200120 China, Zhejiang Novo Nordisk Investigational Site Hangzhou, Zhejiang, China, 310003 Novo Nordisk Investigational Site Wenzhou, Zhejiang, China, 325000 China Novo Nordisk Investigational Site Hangzhou, China, 310016 Novo Nordisk Investigational Site Nantong, China, 226001 Novo Nordisk Investigational Site Shanghai, China, 200040 Less <<
NCT01797198 Drug-Drug Interaction (DDI) ... More >> Healthy Subjects Less << Phase 1 Completed - United Kingdom ... More >> PAREXEL Early Phase Clinical Unit Harrow, United Kingdom, HA1 3U Less <<
NCT00832481 Type 2 Diabetes Not Applicable Unknown December 2009 China, Beijing ... More >> PLA General Hospital Recruiting Beijing, Beijing, China, 100000 Contact: Dong Cai ?? +86-10-66939246 Less <<
NCT00819741 - Completed - -
NCT02128321 Pharmacokinetics of Repaglinid... More >>e Pharmacokinetics of Caffeine Healthy Subjects Less << Phase 1 Completed - United States, Maryland ... More >> Parexel Early Phase Clinical Unit Baltimore, Maryland, United States, 21225 Less <<
NCT01780051 Diabetes Mellitus, Type 2 Phase 1 Completed - Korea, Republic of ... More >> Chounbuk National University Hospital Jeonju, Jeonbuk, Korea, Republic of Less <<
NCT00959101 Diabetes Heal... More >>thy Less << Phase 1 Completed - China, Beijing ... More >> Beijing, Beijing, China, 100032 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.21mL

0.44mL

0.22mL

11.05mL

2.21mL

1.10mL

22.10mL

4.42mL

2.21mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories